Glucose lowering and diabetes prevention: are they the same?
Open Access
- 19 September 2006
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 368 (9543) , 1218-1219
- https://doi.org/10.1016/s0140-6736(06)69421-x
Abstract
No abstract availableFunding Information
- Meso Scale Diagnostics
- Bayer
- Novo Nordisk
- Novartis
- Pfizer
- AstraZeneca
- Sanofi
This publication has 10 references indexed in Scilit:
- Understanding of diabetes prevention studies: questionnaire survey of professionals in diabetes careDiabetologia, 2006
- The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)Diabetologia, 2006
- Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialPublished by Elsevier ,2005
- Prevention of Type 2 Diabetes With Troglitazone in the Diabetes Prevention ProgramDiabetes, 2005
- Is Nondiabetic Hyperglycemia a Risk Factor for Cardiovascular Disease?Archives of internal medicine (1960), 2004
- Longitudinal study of the long-term relation between physical activity and obesity in adultsInternational Journal of Obesity, 2003
- Preservation of Pancreatic β-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic WomenDiabetes, 2002
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose ToleranceNew England Journal of Medicine, 2001
- Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise The 6-year Malm feasibility studyDiabetologia, 1991